000 | 01039 a2200277 4500 | ||
---|---|---|---|
005 | 20250511202005.0 | ||
264 | 0 | _c19920123 | |
008 | 199201s 0 0 eng d | ||
022 | _a0147-8389 | ||
024 | 7 |
_a10.1111/j.1540-8159.1991.tb02745.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChirife, R | |
245 | 0 | 0 |
_aCatheter ablation of ventriculoatrial conduction in the treatment of pacemaker-mediated tachycardia. _h[electronic resource] |
260 |
_bPacing and clinical electrophysiology : PACE _cNov 1991 |
||
300 |
_a1684-5 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aCardiac Pacing, Artificial _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPacemaker, Artificial |
650 | 0 | 4 | _aSoftware |
650 | 0 | 4 |
_aTachycardia _xetiology |
700 | 1 | _aOrtega, D F | |
700 | 1 | _aSalazar, A I | |
773 | 0 |
_tPacing and clinical electrophysiology : PACE _gvol. 14 _gno. 11 Pt 1 _gp. 1684-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1540-8159.1991.tb02745.x _zAvailable from publisher's website |
999 |
_c1727558 _d1727558 |